Puerperal Thromboembolism and Suppression of Lactation

Investigation of relation between use of oral contraceptives and thromboembolic disease.

“…Others were either unrelated to the disease or the relation was so weak that it could have had no material effect on the results. Secondly, there is evidence that oestrogens can cause thromboembolism in other circumstances (Daniel, Campbell, and Turnbull, 1967;Oliver, 1967;Bailar, 1967;Schrogie and Solomon, 1967).…”

Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study

“…This dosage schedule is similar to a regimen once used in all Cardiff hospitals (Daniel et al, 1967). Those receiving ergocryptine were given 5 mg twice daily for the first six days and 5 mg a day for the last three days.…”

Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection.

“…Similar findings hold for postpartum women given estrogen to suppress lactation. 5,6 Thus the increased risk due to use of this medication is not limited to healthy women at what might be considered baseline risk. Perhaps this relationship will be shown to apply to women with chronic diseases as well.…”